Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2010, Vol. 30 Issue (09): 7-12    DOI: Q7R74
    
The Construction of Recombinant Adenovirus Delivering Chimeric Neurturin and Activity Assay in vitro
WANG Wen-ju,SUN Mao-sheng,YAN Min,LI Hong-jun
Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, China
Download: HTML   PDF(926KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Neurturin is a member of neurotrophic family, and the gene engineering product of the Neurturin can promote the survival of the dopaminergic neurons, which is a new approach to the therapy of Parkinson’s disease. However, a few researches have indicated that the wild type of Neurturin cannot be processed and secreted into the medium. Therefore, the study intends to rebuilt the gene of wtNeurturin and replaced the signal peptide of wtNeurturin by the counterpart of NGF. The hybrid Neurturin was inserted into the genome of adenovirus and packaged in AD-293 cells. The chimeric Neurturin could be expressed in cytoplasm of vero cells and be processed and secreted, which was detected by immunofluorescence and Western blotting. Finally, the culture of dorsal root ganglia of chick embryo test had indicated that Neurturin expressed by chimeric gene had good biological activity.



Key wordsNeurturin      Chimeric Gene      Recombinant Adenovirus      In Vitro Activity      Parkinson’s disease     
Received: 05 May 2010      Published: 25 August 2010
Cite this article:

WANG Wen-Ju, SUN Mao-Cheng, YAN Min, LI Hong-Jun. The Construction of Recombinant Adenovirus Delivering Chimeric Neurturin and Activity Assay in vitro. China Biotechnology, 2010, 30(09): 7-12.

URL:

https://manu60.magtech.com.cn/biotech/Q7R74     OR     https://manu60.magtech.com.cn/biotech/Y2010/V30/I09/7

[1] Gasmi M, Herzog C D, Brandon E P, et al. Striatal delivery of neurturin by CERE120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson’s disease. Mol Ther,2007, 15(1):6268. 
[2] Toulouse A, Sullivan A M. Progress in Parkinson’s diseasewhere do we stand? Prog Neurobiol,2008, 85(4):376392. 
[3] Cheng S D, Zhou H Y. Yesterday, Today and Tomorrow of Parkinson’s Disease. Journal of Chinese Neurology, 2006, 39(6):361363. 
[4] Bjorklund T, Kordower J H. Gene therapy for Parkinson’s disease. Mov Disord, 2010, 25(Suppl 1):S161S173. 
[5] Li H, Ma Y, Su T, et al Expression, purification, and characterization of recombinant human neurturin secreted from the yeast Pichia pastoris. Protein Expr Purif, 2003, 30(1):1117. 
[6] Kordower J H, Herzog C D, Dass B, et al. Delivery of neurturin by AAV2 (CERE120)mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTPtreated monkeys. Ann Neurol, 2006, 60(6):706715. 
[7] Kordower J H, Emborg M E, Bloch J, et al. Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson’s Disease. Science, 2000,290(27):767773. 
[8] Hoane M R, Gulwadi A G, Morrison S, et al. Differential in vivo effects of neurturin and glial celllinederived neurotrophic factor. Exp Neurol, 1999, 160(1):235243. 
[9] Georgievska B, Kirik D, Bjrklund A. Overexpression of glial cell linederived neurotrophic factor using a lentiviral vector induces time and dosedependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system. J Neurosci, 2004, 24(29):64376445. 
[10] FjordLarsen L, Johansen J L, Kusk P, et al. Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct. Exp Neurol, 2005, 195(1):4960. 
[11] Suter U,Heymach J V,Shooter E M. Two conserved domain in the NGF propeptide are necessary and sufficient for the biosynthesis of correctly processed and biologically active NFG. EMBO J, 1991,10(9):23952400.

[1] HUANG Lei,WAN Chang-qing,LIU Mei-qin,ZHAO Min,ZHENG Yan-peng,PENG Xiang-lei,YU Jie-mei,FU Yuan-hui,HE Jin-sheng. Construction of Recombinant Adenovirus Vectors Using the DNA Assembly Method[J]. China Biotechnology, 2021, 41(6): 23-26.
[2] ZHOU Yan, WANG Xiao-nan, YAN Shan-shan, WU Jin-yuan, SUN Mao-sheng, ZHANG Lei, LI Hong-jun. Construction and Coexpression of Recombinant Adenovirus Containing EGFP and Lmx1A[J]. China Biotechnology, 2014, 34(9): 72-79.
[3] ZHOU Ting-ting, PAN Chuan-yong, ZHANG Jian-peng, JIN Hui-ying. The Research of the Glycosylation of Sodium Channel β4 Subunit[J]. China Biotechnology, 2014, 34(7): 10-16.
[4] ZHOU Nian, HU Ning, GONG Xuan, WANG Chang-dong, LIAO Jun-yi, LIANG Xi, HUANG Wei. Construction and Identification of Recombinant Adenovirus Ad-HIF1α[J]. China Biotechnology, 2014, 34(3): 34-40.
[5] XIE Li, WANG Xiao-nan, LI Yang, YAN Min, CAO Yin, LI Hong-jun, SUN Mao-sheng. Construction and Immunogenicity of a Recombinant Adenovirus Expressing NSP4 of Group A Rotavirus[J]. China Biotechnology, 2014, 34(2): 1-6.
[6] LI Chen, GU Hua, GUO Jia, SUN Hui, HUANG Jing-wei, JIANG Ming, JIN Ling-jing, FANG Jian-min. Expression of Tat-MANF Fusion Protein and Its Bioactivity Analysis[J]. China Biotechnology, 2014, 34(06): 7-15.
[7] WANG Wan-pu, SUN Mao-sheng, LI Hong-jun, XIE Tian-hong, YAN Min, ZHOU Yan, YIN Na. Establishment of Bone Marrow Mesenchymal Stem Cells Expressing Neurotrophic Factor Neurturin and Activity Detection in Vitro[J]. China Biotechnology, 2012, 32(03): 1-6.
[8] WANG Jing, HU Jian-He, XU Pan-Shao. Genetic Stability and Titer Determination of Recombinant Adenovirus Expressing HA Gene of Strain H5N1 of Avian Influenza Virus[J]. China Biotechnology, 2010, 30(09): 19-23.
[9] SU Yu-Jin, CAO Qian, LU Ling-Ling, SUN Xiao-Gong, GAO Hua, DIAO Sha-Sha, YANG Hui. Nrf3 Pathway was Involved in the Protection of Astrocyte Against the Neurotoxicity of Rotenone[J]. China Biotechnology, 2010, 30(01): 19-24.
[10] DIAO Chun-Li, CHU Yuan-Gang, DUAN Chun-Li, LU Ling-Ling, ZHANG Ling, YANG Hui. The Influence of α-synuclein Overexpression on Mitochondrial Membrane Structure with Atomic Force Microscopy[J]. China Biotechnology, 2009, 29(11): 12-16.
[11] . Construction and identification of replication deficient recombinant adenovirus expressing M Protein of Human Respiratory Syncytial Virus[J]. China Biotechnology, 2008, 28(5): 6-11.